- Home
- NPCE vs OM Comparison
NPCE vs OM Comparison
Compare NPCE & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- OM
- Stock Information
- Founded
- NPCE 1997
- OM 2003
- Country
- NPCE United States
- OM United States
- Employees
- NPCE N/A
- OM N/A
- Industry
- NPCE Medical Specialities
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NPCE Health Care
- OM Health Care
- Exchange
- NPCE Nasdaq
- OM Nasdaq
- Market Cap
- NPCE 312.2M
- OM 305.5M
- IPO Year
- NPCE 2021
- OM 2020
- Fundamental
- Price
- NPCE $8.98
- OM $18.53
- Analyst Decision
- NPCE Strong Buy
- OM Buy
- Analyst Count
- NPCE 6
- OM 2
- Target Price
- NPCE $16.33
- OM $33.00
- AVG Volume (30 Days)
- NPCE 340.9K
- OM 411.2K
- Earning Date
- NPCE 08-12-2025
- OM 08-06-2025
- Dividend Yield
- NPCE N/A
- OM N/A
- EPS Growth
- NPCE N/A
- OM N/A
- EPS
- NPCE N/A
- OM N/A
- Revenue
- NPCE $84,306,000.00
- OM $115,273,000.00
- Revenue This Year
- NPCE $21.04
- OM $10.80
- Revenue Next Year
- NPCE $10.73
- OM $11.99
- P/E Ratio
- NPCE N/A
- OM N/A
- Revenue Growth
- NPCE 22.05
- OM N/A
- 52 Week Low
- NPCE $5.45
- OM $5.85
- 52 Week High
- NPCE $18.98
- OM $59.33
- Technical
- Relative Strength Index (RSI)
- NPCE 31.44
- OM 48.27
- Support Level
- NPCE $9.00
- OM $17.16
- Resistance Level
- NPCE $9.61
- OM $19.60
- Average True Range (ATR)
- NPCE 0.42
- OM 1.17
- MACD
- NPCE 0.05
- OM -0.16
- Stochastic Oscillator
- NPCE 10.61
- OM 35.06
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.